decisionhealth Newsletters, Coder Pink Sheets - 2003 Issue 3 (March)
PSA testing: no more 84153 for BPH
Subscribe or sign in to view the full article.
Article Overview
This article addresses a Medicare coverage update for prostate-specific antigen testing and the impact on billing in cases involving benign prostatic hyperplasia. It is aimed at coders, billers, and urology practices that need to understand the coverage shift, the distinction between screening and diagnostic testing, and the diagnosis-code context discussed in the article.
Why This Topic Matters
It helps practices avoid claims denials tied to an updated national coverage determination and better understand which coding scenarios are being affected by the policy change.
What You Will Learn
- How a Medicare coverage update affected prostate-specific antigen testing
- The difference between screening and diagnostic testing in the article’s discussion
- Which diagnosis-code groupings are discussed in connection with the coverage change
- Why the article highlights Medicare denial risk for certain claims
Who Should Read This
- Medical coders
- Medical billers
- Urology practices
- Revenue cycle staff
Codes Discussed
Code Ranges Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com